What Is Post Cholecystectomy Syndrome?

Post-cholecystectomy syndrome is a broad clinical label for abdominal symptoms that persist or newly appear after gallbladder removal. The term covers everything from lingering pain and bloating to new-onset diarrhea, and it does not point to a single cause. In large studies, roughly a third of patients still report some form of abdominal complaint six months after surgery, even though the operation successfully eliminates the classic gallstone attacks in the vast majority of cases. The challenge, both for patients and doctors, is figuring out which of several very different problems is actually driving the symptoms.

How Common Is It, and What Does It Feel Like

The numbers vary depending on when you measure and what you count. One study following patients after laparoscopic cholecystectomy found that about 58% reported symptoms in the first week, but that figure dropped to 13% by six months, with dyspepsia (a vague upper-abdominal discomfort, sometimes described as indigestion) being the most common remaining complaint.¹ A larger analysis of over 800 patients found that cholecystectomy resolved classic biliary colic in about 95% of cases, but roughly 37% still reported persistent abdominal pain at six months. The symptoms that lingered most often were flatulence (about 18% of patients) and restricted eating (about 15%). New symptoms that had not been present before surgery also appeared: frequent bowel movements, bowel urgency, and new-onset diarrhea each affected roughly 8 to 10% of patients.²

The gap between those two numbers tells you something important about how PCS is defined. If you count any lingering digestive symptom at all, the rate looks high. If you count only the kind of severe episodic pain that gallstones cause, it looks much lower. Many people in the “persistent symptoms” group have mild complaints that are an annoyance rather than a serious problem. But for a meaningful minority, the symptoms are disruptive enough to need further investigation.

Early Versus Late Onset

Doctors broadly divide PCS into early-onset and late-onset presentations, and the distinction matters because the likely causes are different. Early symptoms, those that appear within days to weeks of surgery, tend to stem from surgical complications or incomplete treatment. Retained stones in the cystic duct remnant or common bile duct, bile leaks, and operative injuries to bile ducts all fall into this category.³

Late-onset PCS, developing months or even years later, has a different set of usual suspects. Inflammatory scarring that narrows the bile duct, dysfunction of the sphincter of Oddi (the muscular valve controlling bile and pancreatic juice flow into the small intestine), and newly formed bile duct stones are the common biliary culprits. Non-biliary causes like irritable bowel syndrome and gastroesophageal reflux also show up frequently in this group, sometimes because they were there before surgery and simply unmasked once the gallstone pain resolved.

Biliary Causes

When the problem traces back to the bile duct system itself, the most common finding is retained or recurrent stones in the common bile duct. Studies put this at roughly 2% of all patients after laparoscopic cholecystectomy. One study of nearly 1,500 patients found that about 1.8% required a follow-up procedure to retrieve retained stones, with the median time from surgery to the procedure being about five months.⁴ A separate study of over 1,000 patients found a similar overall rate of about 2.3%, with retained stones tending to be small (around 5 mm).⁵

Stones can also get trapped in the cystic duct stump, the small portion of the duct left behind when the gallbladder is removed. This scenario is less common but well recognized, and the retained calculus can cause pain that closely mimics the original gallstone attacks.⁶

Sphincter of Oddi dysfunction is another major biliary cause. The sphincter normally opens and closes rhythmically to let bile and pancreatic fluid into the intestine. After gallbladder removal, it can become spastic or scarred, causing episodic pain, sometimes accompanied by abnormal liver blood tests or a dilated bile duct on imaging.⁷ This diagnosis has been controversial for years, partly because measuring the sphincter’s pressure requires an invasive test, and partly because treating it does not always help (more on that in the treatment section).

When the Gallbladder Was Never the Whole Problem

A substantial proportion of PCS cases are not biliary at all. One of the most eye-opening findings in PCS research is how often patients have a pre-existing functional gastrointestinal disorder, such as irritable bowel syndrome, that coexisted with their gallstones. In one study, functional gastrointestinal disorders were present in 88% of patients before surgery and 57% afterward. Patients who had no such disorder before surgery experienced nearly complete relief from cholecystectomy. Among those who did have one, only about a third got better after the operation, strongly suggesting that the functional disorder, not the gallstones, had been the dominant source of symptoms all along.⁸

A systematic review of long-term PCS found that coexistent diseases (including functional disorders, peptic ulcer disease, reflux, and pancreatitis) were reported as etiologies in prevalence ranging from 1 to 65% across 64 studies. Psychological distress was also noted as a contributing factor, though specific prevalence rates were not quantified.⁹ This wide range reflects the reality that “post-cholecystectomy syndrome” is an umbrella sheltering many different conditions, and in plenty of cases the gallbladder removal itself was not the cause of the ongoing trouble.

Post-Cholecystectomy Diarrhea

Diarrhea deserves its own discussion because it is one of the more common new-onset symptoms and has a fairly well-understood mechanism. The gallbladder normally stores and concentrates bile between meals. Once it is gone, bile flows continuously from the liver into the small intestine. Most of the time, the small intestine absorbs it efficiently enough. But when excess bile acids spill into the colon, they irritate the lining and stimulate the colon to secrete water and electrolytes, producing watery, urgent stools.¹⁰

For most people, this resolves on its own as the body adjusts over weeks to months. For the roughly 8 to 10% who develop persistent diarrhea, bile acid sequestrants (medications that bind bile acids in the gut) are the standard first-line treatment and are often effective. A low-fat, high-fiber diet can also reduce the bile acid load reaching the colon.¹¹

How Doctors Track Down the Cause

The diagnostic workup for PCS follows a stepwise approach. The first-line tests are blood work (liver function tests) and an abdominal ultrasound. If the common bile duct appears dilated on ultrasound (10 mm or more), but no clear cause is visible, the next step is typically magnetic resonance cholangiopancreatography (MRCP), a non-invasive imaging technique that gives detailed pictures of the bile and pancreatic ducts. If both blood tests and ultrasound are normal, MRCP is generally unnecessary.¹²

When bile duct stones are suspected but imaging is inconclusive, endoscopic ultrasound (EUS) is an option. A meta-analysis comparing EUS to MRCP found that EUS was significantly more sensitive for detecting bile duct stones (97% vs 87% sensitivity), while both had similar specificity. In practice, EUS is often reserved for ambiguous cases because it requires sedation and endoscopy.¹³

Upper endoscopy, CT scans, and specialized motility testing may also enter the picture depending on the clinical picture, especially when non-biliary causes like reflux, peptic ulcers, or gastroparesis are in play. Doctors generally try to rule out structural problems first before turning to functional diagnoses like sphincter of Oddi dysfunction or irritable bowel syndrome.

Treatment Depends Entirely on the Cause

There is no single treatment for PCS because there is no single cause. The management strategy depends on what the workup reveals.

Retained stones: These are typically retrieved through endoscopic retrograde cholangiopancreatography (ERCP), a procedure that uses a scope passed through the mouth to access the bile duct. For stones stuck in the cystic duct remnant, newer techniques using cholangioscopy-guided lithotripsy (breaking stones apart under direct visualization) have emerged as alternatives, though about half of cystic duct remnant stone cases still end up needing surgery.¹⁴
Sphincter of Oddi dysfunction: Sphincterotomy (cutting the sphincter muscle during ERCP) was once widely performed, but the landmark EPISOD trial found no significant reduction in pain compared to a sham procedure. This has pushed doctors toward more conservative approaches, and the diagnosis itself is made less frequently than it used to be.¹⁴
Bile acid diarrhea: Bile acid sequestrants like cholestyramine, along with dietary adjustments emphasizing lower fat and higher fiber, are the mainstay.¹⁰
Functional GI disorders: Standard treatments for the specific condition apply, whether that means antispasmodics for irritable bowel syndrome, proton pump inhibitors for reflux, or dietary changes.

Individualized treatment plans are essential. A patient whose pain is from a retained stone needs a completely different approach than one whose symptoms stem from undiagnosed irritable bowel syndrome, even though both fall under the PCS umbrella.

Who Is Most Likely to Develop It

Certain risk factors measured before surgery predict a higher chance of persistent symptoms afterward. A prospective study found that pre-operative bloating, constipation, and current or previous use of psychiatric medications were all significantly more common among patients who had poor outcomes after laparoscopic cholecystectomy.¹⁵ These findings fit the broader pattern: patients whose symptoms before surgery included a lot of non-specific complaints (bloating, constipation, vague discomfort) rather than classic sharp, episodic gallstone pain were more likely to keep having problems.

Psychological factors also play a role. Anxiety and depression are overrepresented in PCS populations, and the systematic review literature consistently identifies psychological distress as a contributing factor, even if precise prevalence is hard to pin down.⁹ This does not mean symptoms are imaginary. It means the interplay between gut and brain function is real, and patients with higher psychological distress may experience pain differently or may have had functional disorders that overlapped with their gallstone disease.

The practical takeaway is that careful patient selection before surgery matters. If a patient’s symptoms do not fit the classic gallstone pain profile, or if they have significant functional GI complaints alongside gallstones, the surgeon and patient should have a realistic conversation about what surgery will and will not fix.

How Gallbladder Removal Reshapes the Gut Microbiome

An emerging area of research looks at how removing the gallbladder changes the bacterial ecosystem in the intestines. Bile acids are powerful antimicrobial agents, and when their flow pattern changes, it can shift which bacteria thrive. One study comparing patients with post-cholecystectomy diarrhea to those without it found significant decreases in microbial diversity in the diarrhea group, along with reductions in beneficial bacteria like Bifidobacterium and Lactococcus and increases in potentially harmful species.¹⁶

A case-control study found that people who had undergone cholecystectomy had fewer total bacterial species and greater gut microbiome dissimilarity compared to controls. Specific changes included increases in certain Firmicutes species.¹⁷ However, the picture is not entirely consistent. A before-and-after study measuring the same patients’ microbiomes before and after cholecystectomy found that overall diversity did not change significantly, and only a handful of bacterial species shifted in abundance.¹⁸

The conflicting findings likely reflect differences in study design, patient populations, timing of sampling, and the inherent variability of the human microbiome. What seems reasonably clear is that at least some people experience meaningful shifts in gut bacteria after cholecystectomy, and these shifts may contribute to digestive symptoms, particularly diarrhea. Whether probiotics or targeted microbiome therapies could help remains speculative at this point.

Gallbladder Removal and Long-Term Liver Health

Beyond digestive symptoms, there is growing interest in whether cholecystectomy affects metabolic health over time, particularly the risk of non-alcoholic fatty liver disease (NAFLD). A large meta-analysis covering 27 million individuals found that cholecystectomy was associated with a 54% increased risk of developing NAFLD.¹⁹ The proposed mechanisms include altered bile acid metabolism, gut microbiome disruption, and changes in how the body handles lipids, all consequences of losing the gallbladder’s storage and concentration function.²⁰

The relationship is complicated by the fact that the conditions that lead to gallstones, including obesity, insulin resistance, and abnormal lipid metabolism, are the same conditions that cause fatty liver. So cholecystectomy and NAFLD share risk factors, and untangling whether the surgery itself contributes, or whether both are downstream effects of the same metabolic problems, is difficult.²¹ Researchers describe the relationship as bidirectional: liver steatosis promotes gallstone formation, and gallstone disease (and its surgical treatment) may in turn promote further liver fat accumulation. For patients, the practical implication is that maintaining a healthy weight and managing metabolic risk factors remains important after cholecystectomy, not just for general health but potentially for liver protection as well.

1
PubMed Central. Post-cholecystectomy syndrome: A new look at an old problem
2
PubMed. Persistent and new-onset symptoms after cholecystectomy in patients with uncomplicated symptomatic cholecystolithiasis: A post hoc analysis of 2 prospective clinical trials
3
British Journal of Radiology. Post-cholecystectomy syndrome: spectrum of biliary findings at magnetic resonance cholangiopancreatography
4
PubMed Central. Prevalence and characteristics of clinically significant retained common bile duct stones after laparoscopic cholecystectomy for symptomatic cholelithiasis
5
PubMed. Gallstone size related to incidence of post cholecystectomy retained common bile duct stones
6
PubMed Central. Surgical Management of Cystic Duct Stump Stone or Gall Bladder Remnant Stone
7
PubMed Central. Dysfunction of Biliary Sphincter of Oddi-Clinical, Diagnostic and Treatment Challenges
8
PubMed Central. Post-cholecystectomy symptoms were caused by persistence of a functional gastrointestinal disorder
9
Gastroenterology Research and Practice. Etiologies of Long-Term Postcholecystectomy Symptoms: A Systematic Review
10
PubMed Central. Diagnosis and treatment of post-cholecystectomy diarrhoea
11
Current Medicinal Chemistry. Diet After Cholecystectomy
12
PubMed. Imaging patients with “post-cholecystectomy syndrome”: an algorithmic approach
13
PubMed. Diagnostic accuracy of EUS compared with MRCP in detecting choledocholithiasis: a meta-analysis of diagnostic test accuracy in head-to-head studies
14
PubMed Central. Clinical perspectives on post-cholecystectomy syndrome: a narrative review
15
Gut. Incidence of persistent symptoms after laparoscopic cholecystectomy: a prospective study
16
PubMed Central. Changes in gut microbiota composition and diversity associated with post-cholecystectomy diarrhea
17
PubMed Central. The Impact of Cholecystectomy on the Gut Microbiota: A Case-Control Study
18
PubMed Central. Alteration of the fecal microbiome in patients with cholecystectomy: potential relationship with postcholecystectomy diarrhea – before and after study
19
PubMed Central. Cholecystectomy and risk of liver disease: a systematic review and meta-analysis of 27 million individuals
20
PubMed Central. Cholecystectomy and non-alcoholic fatty liver disease: Exploring the hidden connection and implications
21
PubMed. Cholecystectomy as a risk factor for non-alcoholic fatty liver disease development